Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 11, 2018 00:24:03
Episode Cover

Bicarbonate for Severe Acidosis?

Many critically ill patients are acidotic.  Often, bicarbonate is administered to severely acidotic patients, but does it really improve outcomes?  The BICAR-ICU was just...

Listen

Episode 0

February 14, 2017 00:29:35
Episode Cover

Surviving Sepsis Campaign 2016 Update

The SSC recently published its new recommendations for the management of sepsis and septic shock.  We discuss the key changes and controversies that you...

Listen

Episode 0

February 04, 2020 00:20:31
Episode Cover

Identifying and Treating EVALI

In recent years, the use of e-cigarette and vaping products has sharply risen.  Concomitant with the increased use is an increase in patients presenting...

Listen